(VIANEWS) – NASDAQ Composite ended the session with Sorrento Therapeutics (SRNE) rising 8.4% to $9.03 on Wednesday while NASDAQ Composite jumped 0.92% to $14,631.95.


Today’s last reported volume for Sorrento Therapeutics is 9201710, 26.44% above its average volume of 7277700.

Sorrento Therapeutics’s last close was $8.33, 57.04% under its 52-week high of $19.39.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 53.9% for the current quarter and 56.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 52.8% and 45.5%, respectively.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 46.52M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sorrento Therapeutics’s stock is considered to be oversold (<=20).

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $9.03 at 20:48 EST, way under its 52-week high of $19.39 and way above its 52-week low of $5.17.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s value is above its 50-day moving average of $8.83 and below its 200-day moving average of $9.19.

More news about Sorrento Therapeutics (SRNE).


Please enter your comment!
Please enter your name here